Stock IMPL IPI LEGACY LIQUIDATION CO
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News IPI Legacy Liquidation Co

Equities

IMPL

US45258K1097

Delayed OTC Markets
Other stock markets
 19:08:57 05/04/2024 BST 		5-day change 1st Jan Change
0.015 USD 0.00% Intraday chart for IPI Legacy Liquidation Co 0.00% -87.85%
04-12 North American Morning Briefing : Big Banks Kick -2- DJ
04-05 North American Morning Briefing : Investors on -2- DJ

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
North American Morning Briefing : Big Banks Kick -2-
DJ
North American Morning Briefing : Investors on -2-
DJ
IPI Legacy Liquidation Co Went Out of Business
CI
Second Revised First Amended Liquidation Plan Approved for IPI Legacy Liquidation Co
CI
North American Morning Briefing : Stocks Struggle After New Records
DJ
Impel Pharmaceuticals Inc. has Changed its Name to IPI Legacy Liquidation Co
CI
Combined Disclosure Statement Conditionally Approved for Impel Pharmaceuticals Inc.
CI
First Amended Joint Liquidation Plan and Disclosure Statement Filed by Impel Pharmaceuticals Inc.
CI
Impel Pharmaceuticals Inc. Announces Departure of Len Paolillo as Interim Chief Executive Officer
CI
Joint Liquidation Plan and Disclosure Statement Filed by Impel Pharmaceuticals Inc.
CI
An undisclosed buyer completed the acquisition of substantially all assets of Impel Pharmaceuticals Inc. for $17.5 million.
CI
Motion for Asset Sale Approved for Impel Pharmaceuticals Inc.
CI
Notice of Winning Bidder Filed by Impel Pharmaceuticals Inc.
CI
Notice of Auction Cancellation Filed by Impel Pharmaceuticals Inc.
CI
Bidding Procedure Approved for Impel Pharmaceuticals Inc.
CI
Impel Pharmaceuticals : ORDER (I) APPROVING NOTIFICATION AND HEARING PROCEDURES FOR CERTAIN TRANSFERS OF AND DECLARATION OF WORTHLESSNESS WITH RESPECT TO COMMON STOCK AND (II) GRANTING RELATED RELIEF - Form 8-K
PU
Motion for Joint Administration Approved for Impel Pharmaceuticals Inc.
CI
Impel Pharmaceuticals : Announces Filing Voluntary Chapter 11 Cases and Signing of "Stalking Horse" Agreement to Facilitate Sale - Form 8-K
PU
Impel Pharmaceuticals Inc. Appoints Brandon Smith as Chief Restructuring Officer
CI
Impel Pharmaceuticals Files for Chapter 11 to Facilitate Sale
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMPL Stock
  4. News IPI Legacy Liquidation Co